MedGenome Appoints Dr. Amit Kakar as New Chairman to Propel Global Health Initiatives

MedGenome announced Dr. Amit Kakar as its new Chairman of the Board, succeeding Dr. Felix Olale. Dr. Kakar, with over 30 years in healthcare and life sciences, aims to continue MedGenome's mission to make healthcare solutions affordable and accessible globally, through genomic research and diagnostics.

MedGenome, a leading global genomics-driven diagnostics and research services company, has announced the appointment of Dr. Amit Kakar as Chairman of its Board, effective immediately.

Dr. Kakar takes over from Dr. Felix Olale, MD, PhD, who has completed his two-year term and will now focus on expanding MedGenome's business in the US and North America. With over 30 years of experience in healthcare and life sciences, Dr. Kakar has been a pivotal member of the MedGenome board since 2022 and is known for his leadership in various healthcare investments and strategic roles across Asia.

Expressing his enthusiasm, Dr. Kakar stated, 'I am honored to be serving as Chairman at an exciting time for the company. MedGenome has been at the forefront of revolutionizing healthcare through its deep technology and innovation capabilities in the field of genomics. I look forward to working closely with the board and management team as we continue to make healthcare solutions affordable and accessible for all.' Mahesh Pratapneni, Group CEO & Co-founder of MedGenome, emphasized the importance of Dr. Kakar's expertise and leadership in guiding the company through its next phase of growth and thanked Dr. Felix for his remarkable contributions.

This appointment underscores MedGenome's commitment to strong governance and its mission to improve global health by providing data-driven insights into complex diseases through genomic research and diagnostics. MedGenome remains the market leader in genetic testing in India and continues to expand its global footprint with operations in the US, India, Singapore, and Africa.

(With inputs from agencies.)